Journal Information
Vol. 5. Issue 2.
Pages 76-79 (March - April 2009)
Share
Share
Download PDF
More article options
Vol. 5. Issue 2.
Pages 76-79 (March - April 2009)
Full text access
Pneumomediastinum and diffuse alveolar pain. Severe interstitial pneumopathy due to dermatomyositis
Neumomediastino y daño alveolar difuso. Afección pulmonar severa por dermatomiositis
Visits
4986
Juan Ramón de Diosa,
Corresponding author
jrdedios@htxa.osakidetza.net

Corresponding author.
, Ana Julia López de Goikoetxeaa, Juan Carlos Vesgaa, Laura Tomásb, Vanesa Zorrillab, José Luis Lobob
a Department of Rheumatology, Hospital de Txagorritxu, Vitoria, Álava, Spain
b Department of Pneumology, Hospital de Txagorritxu, Vitoria, Álava, Spain
This item has received
Article information
Abstract

We have recently observed the case of a 36-year-old man with dermatomyositis of recent onset, who developed massive pneumomediastinum and subcutaneous emphysema at the onset of a progressive and severe pulmonary disease. Although there were no sign of parenchymal cysts, after the bronchoscopy it was possible to observe endobronchial necrotic injury, which was considered as the likely source of the air leak. He was treated with high dose of corticosteroids, cyclophosphamide and cyclosporin A that resulted in the disappearance of the pneumomediastinum and subcutaneous emphysema and the progressive improvement of both parenchymal lung disease and respiratory insufficiency, enabled us to progressively taper the dose of corticosteroids.

Keywords:
Dermatomyositis
Pneumomediastinum
Subcutaneous emphysema
Resumen

Presentamos el caso de un varón de 36 años con dermatomiositis de reciente comienzo, que desarrolló neumomediastino y enfisema subcutáneo masivo al inicio de una neumopatía intersticial progresiva y severa. En el momento del diagnóstico no había imágenes parenquimatosas quísticas evidentes; sin embargo, la broncoscopia permitió evidenciar una lesión endobronquial de aspecto necrótico que se consideró como probable origen de la fuga aérea. El paciente se trató con corticoides a dosis altas, ciclofosfamida y ciclosporina A, con resolución del neumomediastino y del enfisema subcutáneo. Con el tratamiento se observó una mejoría progresiva de la afección parenquimatosa pulmonar y de la insuficiencia respiratoria, lo que permitió la disminución progresiva de los corticoides.

Palabras clave:
Dermatomiositis
Neumomediastino
Enfisema subcutáneo
Full text is only aviable in PDF
References
[1.]
H. Kono, S. Inokuma, H. Nakayama, M. Suzuki.
Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy.
Ann Rheum Dis, 59 (2000), pp. 372-376
[2.]
F.S. Neves, S.K. Shinjo, J.F. Carvalho, M. Levy-Neto, C.T.L. Borges.
Spontaneous pneumomediastinum and dermatomyositis may be a not so rare association: report of a case and review of the literature.
Clin Rheumatol, 26 (2007), pp. 105-107
[3.]
C. Korkmaz, R. Özkan, M. Akay, T. Hakan.
Pneumomediastinum and subcutaneous emphysema associated with dermatomyositis.
Rheumatology, 40 (2001), pp. 476-478
[4.]
Y. Yamanishi, H. Maeda, F. Konishi, K. Hiyama, S. Yamana, S. Ishioka.
Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum.
Scand J Rheumatol, 28 (1999), pp. 58-61
[5.]
J.D. Bradley.
Spontaneous pneumomediastinum in adult dermatomyositis.
Ann Rheum Dis, 45 (1986), pp. 780-782
[6.]
T.L. Jansen, P. Barrera, B.G. van Engelen, N. Cox, R.F. Laan, L.B. van de Putte.
Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature.
Clin Exp Rheumatol, 16 (1998), pp. 733-735
[7.]
T. Kuroda, H. Morikawa, Y. Tanabe, S. Murakami, S. Ito, M. Nakan.
A case of dermatomyositis complicated with pneumomediastinum sucessfully treated with ciclosporin A.
Clin Rheumatol, 22 (2003), pp. 45-48
[8.]
E. Carmody, J. McNicholl, G. Chadwick, B. Bresnihan, M.X. Fitzgerald.
Prolonged spontaneous pneumomediastinum in adult dermatomyositis.
Ann Rheum Dis, 46 (1987), pp. 566
[9.]
Y. Matsuda, M. Tomii, S. Kashiwazaki.
Fatal pneumomediastinum in dermatomyositis without creatine kinase elevation.
Intern Med, 32 (1993), pp. 643-647
[10.]
H. Kameda, H. Nagasawa, H. Ogawa, N. Sekiguchi, H. Takei, M. Tokuhira.
Combination therapy with corticosteroids, cyclosporin A and intravenous pulse cyclophosphamide for acute/subacut interstitial pneumonia in patients with dermatomyositis.
J Rheumatol, 32 (2005), pp. 9
[11.]
K. Nagasaka, M. Harigai, M. Taetishi, M. Hara, Y. Yoshizawa, T. Koike.
Efficacy of combined treatment with cyclosporine A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis.
Mod Rheumatol, 13 (2003), pp. 231-238
[12.]
V.A. Barvaux, X. van Mullen, T. Pieters, F.A. Houssiau.
Persistent pneumomediastinum and dermatomyositis: a case report and review of the literature.
Clin Rheumatol, 20 (2001), pp. 359-361
[13.]
C. Powell, B. Kendall, R. Wernick, J.E. Heffner.
A 34-year-old man with amyopathic dermatomyositis and rapidly progressive dyspnea with facial swelling: Diagnosis: Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis-associated interstitial lung disease.
Chest, 132 (2007), pp. 359-361
Copyright © 2009. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?